Trial Profile
Dupilumab Compassionate Use Study
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Mar 2018
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Asthma
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 05 Mar 2018 Status changed from recruiting to completed.
- 18 May 2017 New trial record